Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BAXTER INTERNATIONAL INCBAX · Entity 1707 | Director | March 20, 2023 | March 22, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BAXTER INTERNATIONAL INC
Report date March 20, 2023 · Filed March 22, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, $1 par valueSEC Table I · non-derivative | Direct | 36,835 |
Ending reported balance
After 2023-03-20 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2023-03-20 · Exercise / conversion · Acquired 3,930 · Balance 40,765 F1: Transaction effected pursuant to a Rule 10b-1 trading plan entered into by Mr. Stroucken on February 16, 2023 with respect to certain vested stock options previously granted by Baxter International Inc. to Mr. Stroucken which were scheduled to expire on May 5, 2023. Row 2 · 2023-03-20 · Sale · Disposed 3,930 · Balance 36,835 |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $36.93 · Expires 2023-05-05 | Direct | 0 |
Reported balance
After 2023-03-20 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2023-03-20 · Exercise / conversion · Disposed 3,930 · Balance 0 F1: Transaction effected pursuant to a Rule 10b-1 trading plan entered into by Mr. Stroucken on February 16, 2023 with respect to certain vested stock options previously granted by Baxter International Inc. to Mr. Stroucken which were scheduled to expire on May 5, 2023. |
| Common Stock, $1 par valueSEC Table I · non-derivative | IndirectBy Family Trust | 696 |
Reported balance
Holding disclosure · report date 2023-03-20 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 696 |
Filing footnotes · ownership attribution and instrument terms
F1: Transaction effected pursuant to a Rule 10b-1 trading plan entered into by Mr. Stroucken on February 16, 2023 with respect to certain vested stock options previously granted by Baxter International Inc. to Mr. Stroucken which were scheduled to expire on May 5, 2023.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 20, 2023 Filed Mar 22, 2023 20:05 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | Exercise / conversionStock Option (Right to Buy) · Derivative | 3,930 | $0.00 Strike: $36.93 | $0.00 |
DisclosureSEC source: 0001062993-23-007483 · form4.xml · derivative · entry 4 STROUCKEN ALBERT P L · CIK 0001205438 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $1 par value · 3,930 shares Expires 2023-05-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a Rule 10b-1 trading plan entered into by Mr. Stroucken on February 16, 2023 with respect to certain vested stock options previously granted by Baxter International Inc. to Mr. Stroucken which were scheduled to expire on May 5, 2023. Read SEC document |
| March 20, 2023 Filed Mar 22, 2023 20:05 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | SaleCommon Stock, $1 par value | 3,930 | $37.52 | $147,453.60 |
DisclosureSEC source: 0001062993-23-007483 · form4.xml · nonDerivative · entry 2 STROUCKEN ALBERT P L · CIK 0001205438 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,835 Read SEC document |
| March 20, 2023 Filed Mar 22, 2023 20:05 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | Exercise / conversionCommon Stock, $1 par value | 3,930 | $36.93 | $145,134.90 |
DisclosureSEC source: 0001062993-23-007483 · form4.xml · nonDerivative · entry 1 STROUCKEN ALBERT P L · CIK 0001205438 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,765 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a Rule 10b-1 trading plan entered into by Mr. Stroucken on February 16, 2023 with respect to certain vested stock options previously granted by Baxter International Inc. to Mr. Stroucken which were scheduled to expire on May 5, 2023. Read SEC document |
| May 03, 2022 Filed May 5, 2022 21:26 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | GrantCommon Stock, $1 par value | 2,706 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-011692 · form4.xml · nonDerivative · entry 1 STROUCKEN ALBERT P L · CIK 0001205438 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,834 F1 · shares: The reporting person received a grant of fully vested shares of common stock of Baxter International Inc., subject to the terms and conditions of the applicable grant. Read SEC document |
| April 05, 2022 Filed Apr 7, 2022 20:07 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | Exercise / conversionStock Option (Right to Buy) · Derivative | 4,020 | $0.00 Strike: $29.52 | $0.00 |
DisclosureSEC source: 0001062993-22-009944 · form4.xml · derivative · entry 5 STROUCKEN ALBERT P L · CIK 0001205438 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $1 par value · 4,020 shares Expires 2022-05-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a Rule 10b-1 trading plan entered into by Mr. Stroucken on November 4, 2021 with respect to certain vested stock options previously granted by Baxter International Inc. to Mr. Stroucken which were scheduled to expire on May 8, 2022. Read SEC document |
| April 05, 2022 Filed Apr 7, 2022 20:07 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | SaleCommon Stock, $1 par value | 1,215 | $76.63 | $93,105.45 |
DisclosureSEC source: 0001062993-22-009944 · form4.xml · nonDerivative · entry 3 STROUCKEN ALBERT P L · CIK 0001205438 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,127 F1 · kind: Transaction effected pursuant to a Rule 10b-1 trading plan entered into by Mr. Stroucken on November 4, 2021 with respect to certain vested stock options previously granted by Baxter International Inc. to Mr. Stroucken which were scheduled to expire on May 8, 2022. F3 · price: Price reflects weighted average sales price. Range of prices for transactions are $76.33 through $76.76. Full information regarding the number of shares sold at each separate price will be provided by Baxter International Inc. upon request. Read SEC document |
| April 05, 2022 Filed Apr 7, 2022 20:07 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | SaleCommon Stock, $1 par value | 2,805 | $75.76 | $212,506.80 |
DisclosureSEC source: 0001062993-22-009944 · form4.xml · nonDerivative · entry 2 STROUCKEN ALBERT P L · CIK 0001205438 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,342 F1 · kind: Transaction effected pursuant to a Rule 10b-1 trading plan entered into by Mr. Stroucken on November 4, 2021 with respect to certain vested stock options previously granted by Baxter International Inc. to Mr. Stroucken which were scheduled to expire on May 8, 2022. F2 · price: Price reflects weighted average sales price. Range of prices for transactions are $75.32 through $76.30. Full information regarding the number of shares sold at each separate price will be provided by Baxter International Inc. upon request. Read SEC document |
| April 05, 2022 Filed Apr 7, 2022 20:07 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | Exercise / conversionCommon Stock, $1 par value | 4,020 | $29.52 | $118,670.40 |
DisclosureSEC source: 0001062993-22-009944 · form4.xml · nonDerivative · entry 1 STROUCKEN ALBERT P L · CIK 0001205438 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,147 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a Rule 10b-1 trading plan entered into by Mr. Stroucken on November 4, 2021 with respect to certain vested stock options previously granted by Baxter International Inc. to Mr. Stroucken which were scheduled to expire on May 8, 2022. Read SEC document |
| May 04, 2021 Filed May 6, 2021 22:04 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | GrantCommon Stock, $1 par value | 2,230 | $0.00 | $0.00 |
DisclosureSEC source: 0001205438-21-000002 · edgar.xml · nonDerivative · entry 1 STROUCKEN ALBERT P L · CIK 0001205438 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,126 F1 · shares: The reporting person received a grant of fully vested shares of common stock of Baxter International Inc., subject to the terms and conditions of the applicable grant. Read SEC document |
| April 05, 2021 Filed Apr 7, 2021 22:57 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | Exercise / conversionStock Option (Right to Buy) · Derivative | 4,990 | $0.00 Strike: $31.26 | $0.00 |
DisclosureSEC source: 0001205438-21-000001 · edgar.xml · derivative · entry 4 STROUCKEN ALBERT P L · CIK 0001205438 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $1 par value · 4,990 shares Expires 2021-05-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan entered into by Mr. Stroucken with respect to certain vested stock options previously granted by Baxter International Inc.("BII') to Mr. Stroucken. Read SEC document |
| April 05, 2021 Filed Apr 7, 2021 22:57 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | SaleCommon Stock, $1 par value | 4,990 | $84.56 | $421,954.40 |
DisclosureSEC source: 0001205438-21-000001 · edgar.xml · nonDerivative · entry 2 STROUCKEN ALBERT P L · CIK 0001205438 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,896 F2 · price: Price reflects weighted average sales price. Range of prices for transactions are $84.35 through $84.75. Full information regarding the number of shares sold at each separate price will be provided by BII upon request. Read SEC document |
| April 05, 2021 Filed Apr 7, 2021 22:57 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | Exercise / conversionCommon Stock, $1 par value | 4,990 | $31.26 | $155,987.40 |
DisclosureSEC source: 0001205438-21-000001 · edgar.xml · nonDerivative · entry 1 STROUCKEN ALBERT P L · CIK 0001205438 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,886 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan entered into by Mr. Stroucken with respect to certain vested stock options previously granted by Baxter International Inc.("BII') to Mr. Stroucken. Read SEC document |
| May 05, 2020 Filed May 7, 2020 20:22 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | GrantCommon Stock, $1 par value | 2,197 | $0.00 | $0.00 |
DisclosureSEC source: 0001205438-20-000002 · edgar.xml · nonDerivative · entry 1 STROUCKEN ALBERT P L · CIK 0001205438 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,895 F1 · shares: The reporting person received a grant of fully vested shares of common stock of Baxter International Inc., subject to the terms and conditions of the applicable grant. Read SEC document |
| April 01, 2020 Filed Apr 3, 2020 20:00 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | Exercise / conversionStock Option (Right to Buy) · Derivative | 4,320 | $0.00 Strike: $24.27 | $0.00 |
DisclosureSEC source: 0001205438-20-000001 · edgar.xml · derivative · entry 5 STROUCKEN ALBERT P L · CIK 0001205438 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $1 par value · 4,320 shares Expires 2020-05-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan entered into by Mr. Stroucken with respect to certain vested stock options previously granted by Baxter International Inc.("BII") to Mr. Stroucken. Read SEC document |
| April 01, 2020 Filed Apr 3, 2020 20:00 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | SaleCommon Stock, $1 par value | 3,020 | $80.00 | $241,600.00 |
DisclosureSEC source: 0001205438-20-000001 · edgar.xml · nonDerivative · entry 3 STROUCKEN ALBERT P L · CIK 0001205438 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,698 F3 · price: Price reflects weighted average sales price. Range of prices for transactions are $79.55 through $80.41. Full information regarding the number of shares sold at each separate prce will b providided by BII upon request. Read SEC document |
| April 01, 2020 Filed Apr 3, 2020 20:00 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | SaleCommon Stock, $1 par value | 1,300 | $78.79 | $102,427.00 |
DisclosureSEC source: 0001205438-20-000001 · edgar.xml · nonDerivative · entry 2 STROUCKEN ALBERT P L · CIK 0001205438 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,718 F2 · price: Price reflects weighted average sales price. Range of prices for transactions are $78.47 through $79.19. Full information regarding the number of shares sold at each separate price will be provided by BII upon request. Read SEC document |
| April 01, 2020 Filed Apr 3, 2020 20:00 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | Exercise / conversionCommon Stock, $1 par value | 4,320 | $24.27 | $104,846.40 |
DisclosureSEC source: 0001205438-20-000001 · edgar.xml · nonDerivative · entry 1 STROUCKEN ALBERT P L · CIK 0001205438 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,018 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan entered into by Mr. Stroucken with respect to certain vested stock options previously granted by Baxter International Inc.("BII") to Mr. Stroucken. Read SEC document |
| May 07, 2019 Filed May 9, 2019 20:14 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | GrantCommon Stock, $1 par value | 2,412 | $0.00 | $0.00 |
DisclosureSEC source: 0001205438-19-000002 · edgar.xml · nonDerivative · entry 1 STROUCKEN ALBERT P L · CIK 0001205438 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,698 F1 · shares: The reporting person received a grant of fully vested shares of common stock of Baxter International Inc. subject to the terms and conditions of the applicable grant. Read SEC document |
| April 01, 2019 Filed Apr 3, 2019 21:33 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | Exercise / conversionStock Option (Right to Buy) · Derivative | 5,680 | $0.00 Strike: $26.78 | $0.00 |
DisclosureSEC source: 0001205438-19-000001 · edgar.xml · derivative · entry 4 STROUCKEN ALBERT P L · CIK 0001205438 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $1 par value · 5,680 shares Expires 2019-05-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan entered into by Mr. Stroucken with respect to certain vested stock options granted by Baxter International Inc. to Mr. Stroucken. Read SEC document |
| April 01, 2019 Filed Apr 3, 2019 21:33 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | SaleCommon Stock, $1 par value | 5,680 | $81.89 | $465,135.20 |
DisclosureSEC source: 0001205438-19-000001 · edgar.xml · nonDerivative · entry 2 STROUCKEN ALBERT P L · CIK 0001205438 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,285 Read SEC document |
| April 01, 2019 Filed Apr 3, 2019 21:33 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | Exercise / conversionCommon Stock, $1 par valu | 5,680 | $26.78 | $152,110.40 |
DisclosureSEC source: 0001205438-19-000001 · edgar.xml · nonDerivative · entry 1 STROUCKEN ALBERT P L · CIK 0001205438 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,965 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan entered into by Mr. Stroucken with respect to certain vested stock options granted by Baxter International Inc. to Mr. Stroucken. Read SEC document |
| May 08, 2018 Filed May 10, 2018 20:28 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | GrantCommon Stock, $1 par value | 2,664 | $69.45 | $185,014.80 |
DisclosureSEC source: 0001205438-18-000002 · edgar.xml · nonDerivative · entry 1 STROUCKEN ALBERT P L · CIK 0001205438 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,285 F1 · shares: The reporting person received a grant of 2,664 fully vested shares of common stock of Baxter International Inc. (the "Company"), subject to the terms and conditions of the applicable grant. Read SEC document |
| April 02, 2018 Filed Apr 4, 2018 21:21 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | Exercise / conversionStock Option (Right to Buy) · Derivative | 3,760 | $0.00 Strike: $33.77 | $0.00 |
DisclosureSEC source: 0001205438-18-000001 · edgar.xml · derivative · entry 5 STROUCKEN ALBERT P L · CIK 0001205438 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $1 par value · 3,760 shares Expires 2018-05-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan entered into by Mr. Stroucken with respect to the stock options granted by Baxter International Inc. ("BII") to Mr. Stroucken on May 6, 2008. Read SEC document |
| April 02, 2018 Filed Apr 4, 2018 21:21 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | SaleCommon Stock, $1 par value | 300 | $65.27 | $19,581.00 |
DisclosureSEC source: 0001205438-18-000001 · edgar.xml · nonDerivative · entry 3 STROUCKEN ALBERT P L · CIK 0001205438 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,620 F2 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan entered into by Mr. Stroucken with respect to the stock options granted by BII to Mr. Stroucken. F4 · price: Price reflects weighted average sales price. Range of prices for transactions are $65.22 through $65.35. Full information regarding the number of shares sold at each separate price will be provided by the issuer upon request. Read SEC document |
| April 02, 2018 Filed Apr 4, 2018 21:21 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | SaleCommon Stock, $1 par value | 3,460 | $64.70 | $223,862.00 |
DisclosureSEC source: 0001205438-18-000001 · edgar.xml · nonDerivative · entry 2 STROUCKEN ALBERT P L · CIK 0001205438 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,920 F2 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan entered into by Mr. Stroucken with respect to the stock options granted by BII to Mr. Stroucken. F3 · price: Price reflects weighted average sales price. Range of prices for transactions are $64.19 through $65.18. Full information regarding the number of shares sold at each separate price will be provided by the issuer upon request. Read SEC document |
| April 02, 2018 Filed Apr 4, 2018 21:21 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | Exercise / conversionCommon Stock, $1 par value | 3,760 | $33.77 | $126,975.20 |
DisclosureSEC source: 0001205438-18-000001 · edgar.xml · nonDerivative · entry 1 STROUCKEN ALBERT P L · CIK 0001205438 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,380 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan entered into by Mr. Stroucken with respect to the stock options granted by Baxter International Inc. ("BII") to Mr. Stroucken on May 6, 2008. Read SEC document |
| May 02, 2017 Filed May 4, 2017 21:03 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | GrantCommon Stock, $1 par value | 3,233 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001205438-17-000002 · edgar.xml · nonDerivative · entry 1 STROUCKEN ALBERT P L · CIK 0001205438 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,620 F1 · price: The reporting person received a grant of 3,233 fully vested shares of common stock of Baxter International Inc. (the "Company"), subject to the terms and conditions of the applicable grant. Read SEC document |
| April 10, 2017 Filed Apr 12, 2017 22:01 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | Exercise / conversionStock Option (Right to Buy) · Derivative | 4,280 | $0.00 Strike: $30.73 | $0.00 |
DisclosureSEC source: 0001205438-17-000001 · edgar.xml · derivative · entry 4 STROUCKEN ALBERT P L · CIK 0001205438 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $1 par value · 4,280 shares Expires 2017-05-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan entered into by Mr. Stroucken with respect to the stock options granted by Baxter International Inc. to Mr. Stroucken on May 1, 2007. Read SEC document |
| April 10, 2017 Filed Apr 12, 2017 22:01 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | SaleCommon Stock, $1 par value | 4,280 | $52.80 | $225,984.00 |
DisclosureSEC source: 0001205438-17-000001 · edgar.xml · nonDerivative · entry 2 STROUCKEN ALBERT P L · CIK 0001205438 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,387 F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan entered into by Mr. Stroucken with respect to the stock options granted by Baxter International Inc. to Mr. Stroucken on May 1, 2007. Read SEC document |
| April 10, 2017 Filed Apr 12, 2017 22:01 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | Exercise / conversionCommon Stock, $1 par value | 4,280 | $30.73 | $131,524.40 |
DisclosureSEC source: 0001205438-17-000001 · edgar.xml · nonDerivative · entry 1 STROUCKEN ALBERT P L · CIK 0001205438 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,667 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan entered into by Mr. Stroucken with respect to the stock options granted by Baxter International Inc. to Mr. Stroucken on May 1, 2007. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.